23. [IF=10.2] Piao Luo et al."Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma."Asian Journal of Pharmaceutical Sciences.2023 Nov;18:100874 22. [IF=3.3] Wan Lei et al."A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis."JOURNAL OF PHARMACY AND PHARMACOLOGY.10.1093/jpp/rgad078 21. [IF=3] Ling Ye et al."Celastrol attenuates HFD-induced obesity and improves metabolic function independent of adiponectin signaling."ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY. 20. [IF=11.092] Hongwen Liu et al."Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2-Mediated Unfolded Protein Reaction Activation."Advanced Healthcare Materials.2023 Apr;:2300913 19. [IF=6.533] Liying Guo et al."Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells."JOURNAL OF AFFECTIVE DISORDERS.2022 Nov;316:233 18. [IF=6.656] Si-wei Wang et al."Celastrol inhibits TXNIP expression to protect pancreatic β cells in diabetic mice."PHYTOMEDICINE.2022 Sep;104:154316 17. [IF=3.981] Qian Kang et al."Application of quality by design approach to formulate and optimize tripterine loaded in nanostructured lipid carriers for transdermal delivery."J Drug Deliv Sci Tec. 2019 Aug;52:1032 16. [IF=6.4] Jinran Li et al."Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma."Int J Nanomed. 2020; 15: 1205–1214 15. [IF=6.953] Yun Qian et al."Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment."Int J Biol Macromol. 2021 Jul;183:2215 14. Sun, J, Wang, H-J, Yu, J, Li, T, Han, Y. Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice. Food Sci Nutr. 2020; 8: 6207– 6216. https://doi.org/10.1002/fsn3.1917 13. Kang, Qian, et al. "Application of quality by design approach to formulate and optimize tripterine loaded in nanostructured lipid carriers for transdermal delivery." Journal of Drug Delivery Science and Technology 52 (2019): 1032-1041.https://doi.org/10.10 12. 胡世尚,周圓圓,吳子豪,朱敏,郗雪艷,杜伯雨,喻青青.重樓皂苷Ⅶ對胰腺癌細胞的作用研究[J].湖北醫藥學院學報,2020,39(06):544-550+528 11. 徐佳, 伍春蓮, 黃杰. 雷公藤紅素通過影響Akt信號通路和整合素表達抑制肺癌細胞的轉移[J]. 中國中藥雜志, 2015, 40(006):1129-1133. 10. 徐佳, 伍春蓮. 雷公藤紅素誘導非小細胞肺癌H1299細胞凋亡及其機制研究[J]. 中藥材, 2015, 38(09):1925-1928. 9. 柯波, 萬才水, 李安娜,等. 雷公藤紅素誘導多發性骨髓瘤H929細胞凋亡[J]. 中國病理生理雜志, 2020(3):487-494. 8. 胡紹英, 張振海, 蔣艷榮, et al. 雷公藤紅素膠體二氧化硅緩釋固體分散體研究[J]. 中草藥, 2013(6):692-695. 7. 夏海建, 張振海, 賈曉斌. 雷公藤紅素緩釋滴丸的研究[J]. 中草藥, 2013, 44(7):834-838. 6. 夏海建, 2], 張振海,等. 雷公藤紅素環糊精與油自組裝小珠載藥系統的制備及其體外評價[J]. 中草藥, 2013, 44(019):2672-2676. 5. 吳章, 呂望, 陳新國,等. 雷公藤紅素對高糖誘導的H9C2細胞損傷的保護作用[J]. 溫州醫科大學學報, 2020(1):24-29. 4. 徐佳, 伍春蓮, 彭聰,等. 雷公藤紅素對人肺癌細胞增殖與凋亡的影響[J]. 西華師范大學學報(自然科學版), 2014(1):51-56. 3. 王黎,秦桂芳,柯鴻,魏廣民.雷公藤紅素對人急性早幼粒細胞白血病SCID小鼠移植瘤模型凝血功能的影響[J].中國中醫急癥,2019,28(02):232-235. 2. 陳小云, 張振海, 胡紹英,等. 基于硬脂酸改性納米碳酸鈣的雷公藤紅素緩釋固體分散體的研究[J]. 中國藥學雜志, 2013, 48(16):1380-1384. 1. 胡紹英, 張振海, 蔣艷榮,等. 基于HPMC-硬脂酸的雷公藤紅素緩釋固體分散體的研究[J]. 中國中藥雜志, 2012, 37(020):3052-3055.